Streptokinase‐Induced Serum Sickness: A Case Report
ABSTRACT Serum sickness is rare; however, there is a significant hypersensitivity reaction to streptokinase used in different cardiac problems. Treatment often involves discontinuing the offending agent and administering corticosteroids. This case underscores the complexities of managing prosthetic...
Saved in:
Main Authors: | Bibek Shrestha, Rebicca Pradhan, Pradeep Shrestha, Sudip Bastakoti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.9650 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab-induced serum sickness: Not so uncommon
by: Vikramraj K Jain
Published: (2018-01-01) -
Streptokinase is dispensable in Streptococcus dysgalactiae subspecies equisimilis infections of human dendritic cells
by: Katharina E. Folz, et al.
Published: (2025-01-01) -
Dupilumab-induced serum sickness-like reaction in a pediatric patient
by: S. Minhaj Rahman, BA, et al.
Published: (2025-02-01) -
The β‐domain of streptokinase affects several functionalities, including specific/proteolytic activity kinetics
by: Maryam Rafipour, et al.
Published: (2019-07-01) -
Coronary angiographic assessment of streptokinase efficacy in young patients with ST-elevation myocardial infarction
by: Chetan Solanki, et al.
Published: (2025-02-01)